1. Stavusis, J, Inashkina, I, Jankevics, E, Burnyte, B, Lace, B. 2015. CAV3 gene sequence variations: National Genome Database and clinics. In Acta neurologica Scandinavica, 132, 185-90. doi:10.1111/ane.12369. https://pubmed.ncbi.nlm.nih.gov/25630502/
2. Lory, Philippe, Nicole, Sophie, Monteil, Arnaud. 2020. Neuronal Cav3 channelopathies: recent progress and perspectives. In Pflugers Archiv : European journal of physiology, 472, 831-844. doi:10.1007/s00424-020-02429-7. https://pubmed.ncbi.nlm.nih.gov/32638069/
3. Adler, Arnon, Novelli, Valeria, Amin, Ahmad S, Wilde, Arthur A M, Gollob, Michael H. 2020. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. In Circulation, 141, 418-428. doi:10.1161/CIRCULATIONAHA.119.043132. https://pubmed.ncbi.nlm.nih.gov/31983240/
4. Li, Xue, Hu, Chengyun, Luo, Shanshan, Jiang, Lai, Tang, Chaoliang. 2024. Cav3.2 deletion attenuates nonalcoholic fatty liver disease in mice. In Gene, 929, 148812. doi:10.1016/j.gene.2024.148812. https://pubmed.ncbi.nlm.nih.gov/39116959/
5. El Ghaleb, Yousra, Flucher, Bernhard E. . CaV3.3 Channelopathies. In Handbook of experimental pharmacology, 279, 263-288. doi:10.1007/164_2022_631. https://pubmed.ncbi.nlm.nih.gov/36592228/
6. Meng, Zhijun, Zhang, Zhen, Zhao, Jianli, Ma, Xinliang, Wang, Yajing. 2023. Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in Prediabetic Animals. In Circulation, 147, 1162-1179. doi:10.1161/CIRCULATIONAHA.122.063073. https://pubmed.ncbi.nlm.nih.gov/36883479/
智鼠故事 
